Know Cancer

or
forgot password

    • cancer clinical trials in louisville, KY

    • Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
    Kentuckiana Cancer Institute
    Louisville, Kentucky 40202
    Cancer
    High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma
    Kentuckiana Cancer Institute
    Louisville, Kentucky 40202
    Malignant Glioma
    Genetic Epidemiology of Adult Onset Glioma
    Kentuckiana Cancer Institute
    Louisville, Kentucky 40202
    Adult-Onset Glioma
    Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome
    Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic
    Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Small Cell Lung Cancer, Carcinoma, Small Cell
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    Norton Healthcare, Inc.
    Louisville, Kentucky 40202
    Carcinoma, Non-Small-Cell Lung
    A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate
    Local Institution
    Louisville, Kentucky
    Leukemia, Myeloid, Chronic, Leukemia, Lymphocytic, Acute, L2
    Phase II Trial of Ontak With Metastatic Melanoma
    James Graham Brown Cancer Center, Univ. of Louisville
    Louisville, Kentucky 40202
    Malignant Melanoma
    Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    Priapism, Anemia, Sickle Cell
    Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
    Louisville Oncology Research
    Louisville, Kentucky 40202
    Chronic Myeloid Leukemia
    Safety of TKI258 in Advanced/Metastatic Melanoma Subjects
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Melanoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    The James Graham Brown Cancer Center at University of Louisville
    Louisville, Kentucky 40202
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Carcinoma, Small Cell
    5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Rectal Cancer, Cancer of the Rectum, Colorectal Cancer
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    Neuroblastoma
    Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    Louisville Oncology
    Louisville, Kentucky 40202
    Non-Hodgkin's Lymphoma
    Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
    Norton Healthcare - Louisville Oncology
    Louisville, Kentucky 40202
    Small Cell Lung Cancer
    Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
    Louisville Oncology at Norton Cancer Institute - Louisville
    Louisville, Kentucky 40202
    Colorectal Cancer
    Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
    University of Louisville Cancer Center
    Louisville, Kentucky
    Malignant Ascites
    APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
    Kentuckiana Cancer Institute, PLLC
    Louisville, Kentucky 40202
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease
    University of Louisville
    Louisville, Kentucky 40202
    Graft Versus Host Disease
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    Norton Healthcare - Louisville Oncology
    Louisville, Kentucky 40202
    Small Cell Lung Cancer
    Racial Disparity in Endometrial Cancer
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Endometrial Cancer
    Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Ovarian Cancer
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Esophageal Cancer
    Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Lung Cancer
    A Study of Abatacept in Patients With Active Crohn's Disease
    University of Louisville
    Louisville, Kentucky 40202
    Crohn's Disease
    Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
    Louisville Oncology Clinical Research Program
    Louisville, Kentucky 40202
    Epithelial Ovarian Cancer
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Louisville Oncology at Norton Cancer Institute - Louisville
    Louisville, Kentucky 40202
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    University Medical Center University of Louisville Hospital
    Louisville, Kentucky 40202
    Cytomegalovirus Infections
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Va Medical Center

    Trial Locations
    Va Medical Center
    Norton Cardiovascular Associates
    Atrial Fibrillation, Atrial Flutter
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Drs.Caroll, Sheth and Raghavan
    Louisville, Kentucky 40215
    Prostate Cancer
    First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Lung Cancer
    Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Prostate Cancer
    Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
    Site Facility
    Louisville, Kentucky 40291
    Hypoactive Sexual Desire Disorder
    Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
    Kentuckiana Cancer Institute
    Louisville, Kentucky 40202
    Cachexia
    A Phase I Study of Intraperitoneal Hyperthermic Docetaxel
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Ovarian Carcinoma
    Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Anemia
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    Leukemia
    Ph II Study of Perifosine for Patients With Carcinoma of the Kidney
    Investigative Site
    Louisville, Kentucky 40202
    Kidney Cancer
    Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
    University of Louisville, James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Leukemia, Myeloid
    Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
    University of Louisville
    Louisville, Kentucky 40202
    Melanoma
    A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
    University of Louisville - James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
    University of Louisville, Kentucky Neuroscience Research
    Louisville, Kentucky
    Multiple Sclerosis, Relapsing-Remitting
    Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Breast Cancer
    PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
    James Graham Brown Cancer Center at University of Louisville

    Trial Locations
    James Graham Brown Cancer Center at University of Louisville
    Kentuckiana Cancer Institute, PLLC
    Lung Cancer